Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Revenue
$2.59B
TTM · Period ending: · USD
BIO Revenue
Latest reported$2.59Bperiod ending
Latest reported$2.59Bperiod ending
BIO TTM Revenue ($126.50M → $2.59B)
TTM revenue
High-resolution chart · PNG
BIO revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 767,151,000 | |
| 755,133,000 | |
| 744,866,000 | |
| 725,884,000 | |
| 737,259,000 | |
| 676,673,000 | |
| 607,386,000 | |
| 549,400,000 | |
| 473,800,000 | |
| 459,300,000 | |
| 451,400,000 | |
| 441,900,000 | |
| 438,900,000 | |
| 439,400,000 | |
| 437,300,000 | |
| 427,000,000 | |
| 425,200,000 | |
| 422,300,000 | |
| 416,500,000 | |
| 418,900,000 | |
| 412,800,000 | |
| 409,100,000 | |
| 407,000,000 | |
| 396,600,000 | |
| 385,400,000 | |
| 376,300,000 | |
| 363,500,000 | |
| 355,300,000 | |
| 345,900,000 | |
| 341,000,000 | |
| 337,700,000 | |
| 328,500,000 | |
| 329,300,000 | |
| 329,000,000 | |
| 327,200,000 | |
| 330,300,000 | |
| 324,600,000 | |
| 321,100,000 | |
| 317,600,000 | |
| 310,700,000 | |
| 308,600,000 | |
| 303,000,000 | |
| 295,300,000 | |
| 286,700,000 | |
| 271,200,000 | |
| 256,800,000 | |
| 248,000,000 | |
| 236,200,000 | |
| 224,700,000 | |
| 215,800,000 | |
| 204,800,000 | |
| 199,000,000 | |
| 189,800,000 | |
| 182,600,000 | |
| 172,500,000 | |
| 159,500,000 | |
| 149,400,000 | |
| 141,500,000 | |
| 134,000,000 | |
| 126,500,000 | |
| 119,700,000 | |
| 114,000,000 |